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The gene product of the X region was examined in simian lymphoid cell lines producing simian T-cell leuke- 
mia virus (STLV), which is closely related to human T-cell leukemia virus (HTLV). By use of specific anti- 
bodies against pX peptides of HTLV-I, a protein of 41 kDa was identified as a pX product of STLV. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Simian T-cell leukemia virus (STLV) is the ex- 
ogenous retrovirus that naturally infects non- 
human primates of Old World origin [l-3]. This 
virus immortalizes normal lymphoid cells of 
human and non-human primates in culture [4-a], 
and it is possibly associated with lymphoid 
malignancy in non-human primates [7,8]. The 
genome of STLV has an additional unique region 
termed ‘X’ other than the usual components of the 
retroviral genome, gag, pal, env and 2 LTRs 
19, IO]. Although there is some species pecificity in 
the STLV genome, the nucleotide sequence of all 
STLV is highly homologous to that of human T- 
cell leukemia virus type I (HTLV-I) [6,9-l 11. The 
gene product of the X region of HTLV has been 
identified as a protein of 40-42 kDa in HTLV-I 
[12-151 and 37-38 kDain HTLV-II [14,15], and its 
function of trans activation of transcription has 
been discussed with regard to its possible relation 
to oncogenesis [ 16- 181. However, the gene expres- 
sion of the X region of STLV has not yet been 
reported. In this work, we detected the X gene 
product of STLV in virus-producing cell lines. 
2.1. Cells 
Three cell lines harboring STLV were used, 
PtM3, BM5 and MtM/R~26, which all contained 
STLV from macaque species, that is, a pig-tailed 
macaque, a bonnet monkey and a red-faced ma- 
caque, respectively [5]. 
2.2. Antisera 
Antisera were prepared against 2 peptides, OP-1 
and bGH-p40x’. OP-1, the tetrade~a~ptide 
of Cys-Pro-Glu-His-Gln-Ile-Thr-Trp-Asp-Pro-Ile- 
Asp-Gly-Arg [ 141 was synthesized chemically. This 
sequence corresponds to that from amino acid 49 
to 62 of the X gene product of HTLV-I [19]; 12 of 
the 14 amino acids are identical to that of STLV 
derived from pig-tailed macaque [lo]. bGH-p4@, 
which was produced as a fused protein with bovine 
growth hormone in ~c~er~c~ia co/i, covers 54 
amino acids located at the COOH terminus of the 
X gene product of HTLV-I (20],42 amino acids of 
which were identical to those of STLV derived 
from pig-tailed macaque [lo]. Antisera against 
OP-1 and bGH-p4@ were prepared in rabbits and 
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guinea pigs. Anti-OP-1 serum reacts with the gene 
products of the X regions of both HTLV-I and 
HTLV-II [14] while anti-bGH-p40X’ serum reacts 
with the product of HTLV-I, but not with that of 
HTLV-II [20]. 
2.3. Immunoprecipitation 
3 x lo6 cells of a simian cell line were labeled 
with lOO,&/ml of [3SS]cysteine for I5 h and then 
lysed according to the method of Yamamoto et al. 
1211. The acid-insoluble fraction of each cell lysate 
(- 1 x lo6 cpm) was incubated with 5 ~1 of each an- 
tiserum or the corresponding preimmune serum 
for 16 h at 4°C. Then, the immune complex was 
treated with 5 mg protein A Sepharose for 16 h at 
4°C. After extraction with buffer containing 1% 
SDS for 2 min at 90°C, the immunoprecipitated 
proteins were subjected to electrophoresis on 12% 
polyacrylamide gel cont~ning 0.1% SDS [22]. 
Subsequently the gel was dried and subjected to 
autoradiography. The specificity of the reaction 
was examined by a competition experiment with 
the pX peptides. For this, 1Opg of each polypep- 
tide used as immunogen was incubated with 5 pl of 
antiserum for 16 h at 4°C before the procedure 
described above. 
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Fig. 1 .Immunoprecipitation of cell lysates with antisera 
against peptides corresponding to parts of the amino 
acid sequence of the X gene product of HTLV-I. (A) 
[%]Cysteine-labeled cell lysate of BMS. The lysate was 
precipitated with rabbit preimmune serum (lane a), rab- 
bit anti-OP-1 serum (lane b), rabbit anti-OP-1 serum 
previously treated with OP-1 (lane c), guinea-pig preim- 
mune serum (lane d), guinea-pig anti-bGH-p40X’ serum 
(lane e) and guinea-pig anti-bGH-pW’ serum previously C 
treated with bGH-p40*’ (lane f). (B) [35S]Cysteine- 
Iabeled cell lysate of R~/mfm~. The sera used for im- 9 h i i k 
munoprecipitation were arranged in the same order as in 
A. (C) [3SS]Cysteine-labeled cell lysate of PtM3. In this 
case, anti-OP-1 as well as anti-bGH-p4@ was prepared 
in guinea pigs. Then, the lysate was precipitated with 
guinea-pig preimmune serum (lane g), guinea-pig anti- .- 
OP-1 serum (lane h), guinea-pig anti-Up-1 serum 
previously treated with OP-1 (lane i), guinea-pig anti- 
bGH-p40X’ serum (lane j) and guinea-pig anti-bGH-pW’ 
previously treated with bGH-p4W’ (lane k). Arrows in- 
dicate the position of 41 kD protein. Numbers represent 
sizes of ovalbumin (43 kDa) and carbonic anhydrase (30 
kDa) used as size markers. 
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3. RESULTS AND DISCUSSION 
As shown in fig. lA, in BM5 cells carrying 
STLV from a bonnet monkey a protein of 41 kDa 
was detected with antisera against OP-1 and bGH- 
p40”‘, but not with preimmune sera. Its detection 
was due to a specific antigen-antibody reaction, 
since its detection was completely prevented by the 
relevant peptides. This 41 kDa protein was not 
detected with either of these antisera against pX 
peptides in cultured lymphocytes of a STLV- 
negative bonnet monkey. These results showed 
that this 41 kDa protein was a gene product of the 
X region of STLV. Furthermore, this X gene 
product of STLV was almost the same size as that 
of HTLV-I [12-151. As shown in fig.lB and C, the 
putative X gene product of each STLV was also 
found in MtM/RfM26 and PtM3 cell lines, which 
produce STLV from a red-faced macaque and a 
pig-tailed macaque, respectively. In both cell lines, 
a protein of 41 kDa was detected with both anti- 
OP-1 and anti-bGH-40”‘, and immunoprecipita- 
tion of this protein was completely inhibited by the 
relevant peptides, like that of the 41 kDa protein in 
BMS cells. 
From these results, this 41 kDa protein was con- 
cluded to be a product of the X region of STLV 
derived from these 3 macaques. Furthermore, this 
product of the X region of STLV seems to be more 
closely related to the product of HTLV-I than to 
that of HTLV-II since it was detected with an- 
tiserum that reacted with the X gene product of 
HTLV-I, but not with that of HTLV-II. In addi- 
tion to this protein, a faint band of 44 kDa was 
observed when a lysate of PtM3 cells was 
precipitated with anti-OP-1, and this im- 
munoprecipitation reaction was inhibited com- 
petitively by the OP-1 peptide. However, the 44 
kDa protein in this cell line was not detected with 
anti-bGH-p40”‘. The nature of the protein in this 
band is unknown, but it might be another X gene 
product of STLV in PtM3 cells. 
The X region of STLV provirus does not show 
significant homology with simian cellular DNA 
free of STLV (not shown), and sero-epidemio- 
logical data indicate that there are many healthy 
carriers of STLV [l-3]. Thus the X region of 
STLV is unlikely to be a typical type of oncogene. 
In other retroviruses of the HTLV family, the X 
gene product has been shown to have a function of 
truns activation, and the possible relation between 
this function and the oncogenesis by the viruses 
has been discussed [16-181. Further studies on the 
function of the X gene product of STLV should 
provide information on the mechanism of 
leukemogenesis by HTLV family viruses. 
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